365 related articles for article (PubMed ID: 16543893)
1. Induction of epidermolysis bullosa acquisita in mice by passive transfer of autoantibodies from patients.
Woodley DT; Ram R; Doostan A; Bandyopadhyay P; Huang Y; Remington J; Hou Y; Keene DR; Liu Z; Chen M
J Invest Dermatol; 2006 Jun; 126(6):1323-30. PubMed ID: 16543893
[TBL] [Abstract][Full Text] [Related]
2. Passive transfer of autoantibodies from a patient with mutilating epidermolysis bullosa acquisita induces specific alterations in the skin of neonatal mice.
Borradori L; Caldwell JB; Briggaman RA; Burr CE; Gammon WR; James WD; Yancey KB
Arch Dermatol; 1995 May; 131(5):590-5. PubMed ID: 7741548
[TBL] [Abstract][Full Text] [Related]
3. Evidence that anti-type VII collagen antibodies are pathogenic and responsible for the clinical, histological, and immunological features of epidermolysis bullosa acquisita.
Woodley DT; Chang C; Saadat P; Ram R; Liu Z; Chen M
J Invest Dermatol; 2005 May; 124(5):958-64. PubMed ID: 15854036
[TBL] [Abstract][Full Text] [Related]
4. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
[TBL] [Abstract][Full Text] [Related]
5. Epidermolysis bullosa acquisita: what's new?
Ishii N; Hamada T; Dainichi T; Karashima T; Nakama T; Yasumoto S; Zillikens D; Hashimoto T
J Dermatol; 2010 Mar; 37(3):220-30. PubMed ID: 20507385
[TBL] [Abstract][Full Text] [Related]
6. Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen.
Sitaru C; Mihai S; Otto C; Chiriac MT; Hausser I; Dotterweich B; Saito H; Rose C; Ishiko A; Zillikens D
J Clin Invest; 2005 Apr; 115(4):870-8. PubMed ID: 15841176
[TBL] [Abstract][Full Text] [Related]
7. Binding of avian IgY to type VII collagen does not activate complement and leucocytes and fails to induce subepidermal blistering in mice.
Sesarman A; Mihai S; Chiriac MT; Olaru F; Sitaru AG; Thurman JM; Zillikens D; Sitaru C
Br J Dermatol; 2008 Mar; 158(3):463-71. PubMed ID: 18205879
[TBL] [Abstract][Full Text] [Related]
8. Childhood epidermolysis bullosa acquisita with autoantibodies against the noncollagenous 1 and 2 domains of type VII collagen: case report and review of the literature.
Mayuzumi M; Akiyama M; Nishie W; Ukae S; Abe M; Sawamura D; Hashimoto T; Shimizu H
Br J Dermatol; 2006 Nov; 155(5):1048-52. PubMed ID: 17034540
[TBL] [Abstract][Full Text] [Related]
9. B cells, dendritic cells, and macrophages are required to induce an autoreactive CD4 helper T cell response in experimental epidermolysis bullosa acquisita.
Iwata H; Bieber K; Tiburzy B; Chrobok N; Kalies K; Shimizu A; Leineweber S; Ishiko A; Vorobyev A; Zillikens D; Köhl J; Westermann J; Seeger K; Manz R; Ludwig RJ
J Immunol; 2013 Sep; 191(6):2978-88. PubMed ID: 23960233
[TBL] [Abstract][Full Text] [Related]
10. Autoimmunity to type VII collagen: epidermolysis bullosa acquisita.
Remington J; Chen M; Burnett J; Woodley DT
Curr Dir Autoimmun; 2008; 10():195-205. PubMed ID: 18460887
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of epidermolysis bullosa acquisita, an autoimmune subepidermal bullous disease.
Hashimoto T; Ishii N; Ohata C; Furumura M
J Pathol; 2012 Sep; 228(1):1-7. PubMed ID: 22692770
[TBL] [Abstract][Full Text] [Related]
12. The cartilage matrix protein subdomain of type VII collagen is pathogenic for epidermolysis bullosa acquisita.
Chen M; Doostan A; Bandyopadhyay P; Remington J; Wang X; Hou Y; Liu Z; Woodley DT
Am J Pathol; 2007 Jun; 170(6):2009-18. PubMed ID: 17525268
[TBL] [Abstract][Full Text] [Related]
13. Epidermolysis bullosa acquisita.
Gupta R; Woodley DT; Chen M
Clin Dermatol; 2012; 30(1):60-9. PubMed ID: 22137228
[TBL] [Abstract][Full Text] [Related]
14. Clearance rates of circulating and tissue-bound autoantibodies to type VII collagen in experimental epidermolysis bullosa acquisita.
Kasperkiewicz M; Hirose M; Recke A; Schmidt E; Zillikens D; Ludwig RJ
Br J Dermatol; 2010 May; 162(5):1064-70. PubMed ID: 20222918
[TBL] [Abstract][Full Text] [Related]
15. Epidermolysis bullosa acquisita.
Kim JH; Kim SC
J Eur Acad Dermatol Venereol; 2013 Oct; 27(10):1204-13. PubMed ID: 23368767
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and diagnosis of epidermolysis bullosa acquisita.
Vorobyev A; Ludwig RJ; Schmidt E
Expert Rev Clin Immunol; 2017 Feb; 13(2):157-169. PubMed ID: 27580464
[TBL] [Abstract][Full Text] [Related]
17. Familial epidermolysis bullosa acquisita.
Noe MH; Chen M; Woodley DT; Fairley JA
Dermatol Online J; 2008 Dec; 14(12):2. PubMed ID: 19265615
[TBL] [Abstract][Full Text] [Related]
18. Induction of complement-fixing autoantibodies against type VII collagen results in subepidermal blistering in mice.
Sitaru C; Chiriac MT; Mihai S; Büning J; Gebert A; Ishiko A; Zillikens D
J Immunol; 2006 Sep; 177(5):3461-8. PubMed ID: 16920988
[TBL] [Abstract][Full Text] [Related]
19. Anti-type VII collagen autoantibodies, detected by enzyme-linked immunosorbent assay, fluctuate in parallel with clinical severity in patients with epidermolysis bullosa acquisita.
Ito Y; Kasai H; Yoshida T; Saleh MA; Amagai M; Yamagami J
J Dermatol; 2013 Nov; 40(11):864-8. PubMed ID: 24127822
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human IgA1 and IgA2 autoantibodies to type VII collagen induce subepidermal blistering ex vivo.
Recke A; Trog LM; Pas HH; Vorobyev A; Abadpour A; Jonkman MF; van Zandbergen G; Kauderer C; Zillikens D; Vidarsson G; Ludwig RJ
J Immunol; 2014 Aug; 193(4):1600-8. PubMed ID: 25024393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]